PATENT CLAIM ANALYSIS

Application Number: 15746630
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "365000"]

Abstract:
The present invention relates to compound of general formula (I) R 1  is selected from H, aryl and alkyl, R 2  is selected from H, alkyl, aryl and CO—R 6 ; R 3  is selected from H, halogen, alkyl, alkenyl, alkynyl, aryl, NHR 7 , NR 7 R 8 , OR 7  and SR 7 ; R 4  is selected from (C 6 -C 12 ) alkyl, (C 2 -C 12 ) alkenyl, (C 2 -C 12 ) alkynyl and (C 6 -C 10 ) aryl, R 5  represents H, R 6 , aryl, OH, OR 6 , O-aryl, SH, SR 6 , S-aryl, CN, NO 2 , CF 3 , COOR 6 , SO 2 NR 6 R 7 , CONR 6 R 7 , NH 2 , NHR 6 , NH-aryl, NR 6 R 7 , NHCOR 6  or aminoacyl; R 6  is alkyl optionally substituted with halogen, OH, SH, NH 2 , O-alkyl, S-alkyl, NH-alkyl or NH-di(alkyl); R 7  and R 8  identical or different are H or alkyl optionally substituted with halogen, OH, SH, NH 2 , O-alkyl, S-alkyl, NH-alkyl or NH-di (alkyl), their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof. The compounds are useful for the treatment of cancers.

Claim (Index 11):
The method of  claim 8 , wherein the patient is an animal or human.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 2.98837
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14441717', '11575647', '11192009', '11375259', '15750471']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8131407459574793
- 35 USC 102 Novelty (BERT): 0.537098643440147
- Combined Prediction Score: 0.7855365357057461
- Mean Citation Score: 350.141906
- Max Citation Score: 376.95123
- Similarity Product: 285.8982452918905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test